Elevance Health elects Amy Schulman as independent director effective Jan 12, 2026

Elevance Health, Inc.

Amy Schulman, Managing Partner at Polaris Partners, joins Elevance Health board.
Appointed to Audit and Finance Committees; effective January 12, 2026.
Schulman also chairs Alnylam Pharmaceuticals board and is senior lecturer at Harvard Business School.
Board cites ongoing refreshment strategy; Schulman brings healthcare, governance, and investment expertise.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.